ConcertAI

ConcertAI offers data products for medical applications. The firm also provides patient insights solutions and collaborates on research as a service.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Series C29 Mar, 2022
***
***
***
Series B13 Jan, 2020
***
***
***
M/A1 Dec, 2017
***
***
***
Corporate1 Dec, 2011
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to ConcertAI77

Filter by
Sort by
ConcertAI
Dec 12, 2024 Show on chart

Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership

Dewpoint and ConcertAI partner to advance DPTX3186, a novel drug candidate targeting 'undruggable' beta catenin in multiple cancers, leveraging AI/ML platforms for optimized patient outcomes....

ConcertAIhttps://www.concertai.com/news/dewpoint-therapeutics-and-concertai-announce-the-first-phase-of-their-translational-oncology-partnership
ConcertAI
Dec 12, 2024 Show on chart

Dewpoint Therapeutics and ConcertAI Announce the First Phase of ...

Supporting Dewpoint's novel condensate modulating approach to drug previously 'undruggable' therapeutic targets, guided by ConcertAI's Clinico-Genomic ...

https://ca.finance.yahoo.com/news/dewpoint-therapeutics-concertai-announce-first-120000064.html
ConcertAI
Dec 5, 2024 Show on chart

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research...

ConcertAIhttps://www.concertai.com/news/concertai-and-neogenomics-announce-new-ai-software-as-a-service-solution-for-hematology-clinical-research
ConcertAI
Dec 5, 2024 Show on chart

ConcertAI and NeoGenomics Announce New AI Software-as-a ...

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research. The new CTO-H provides the largest, longest and ...

https://www.morningstar.com/news/business-wire/20241205002549/concertai-and-neogenomics-announce-new-ai-software-as-a-service-solution-for-hematology-clinical-research
ConcertAI
Dec 5, 2024 Show on chart

ConcertAI and NeoGenomics Announce New AI Software-as-a ...

Starting in 2023, NeoGenomics and ConcertAI reimagined research solutions that healthcare providers and biopharma would need to manage the growing number of new ...

https://markets.ft.com/data/announce/detail?dockey=600-202412050700BIZWIRE_USPRX____20241205_BW002549-1
Show more (72)

Investors2

Sixth StreetSixth Street
Declaration PartnersDeclaration Partners

ConcertAI Twitter